Opus Genetics
IRD
21 hedge funds and large institutions have $4.44M invested in Opus Genetics in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 23 → 21 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
56% less capital invested
Capital invested by funds: $10.2M → $4.44M (-$5.74M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$110K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$33.6K |
| 3 |
BMC
Benin Management Corp
Wilton,
Connecticut
|
+$32.1K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$16.4K |
| 5 |
BlackRock
New York
|
+$13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.9M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.5M |
| 3 |
Renaissance Technologies
New York
|
-$362K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$173K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$79.9K |
IRD Hedge Fund Activity: Q3 2017 in Review
21 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2017, worth a combined $4.44M — down 56% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IRD and 5 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.
The largest buyer was Zurich Cantonal Bank, opening a new position worth an estimated $110K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.9M sold.
- 21 institutional investors held Opus Genetics (IRD) as of Q3 2017, down from 23 in Q2 2017.
- Funds reported $4.44M of Opus Genetics stock for Q3 2017, down 56% quarter-over-quarter.
- 5 funds opened new Opus Genetics positions in Q3 2017 and 6 closed out, a net change of -1 holder.
- The largest Opus Genetics buyer in Q3 2017 was Zurich Cantonal Bank, an estimated $110K added.
- The largest Opus Genetics seller in Q3 2017 was Susquehanna International Group, an estimated $2.9M sold.
Based on aggregated 13F filings for Q3 2017.